Two Sigma Securities LLC bought a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,067 shares of the insurance provider’s stock, valued at approximately $1,218,000.
Other institutional investors also recently modified their holdings of the company. Johnson Financial Group Inc. bought a new stake in Humana during the 2nd quarter valued at about $26,000. Trust Co. of Vermont bought a new position in shares of Humana in the second quarter worth approximately $28,000. Bogart Wealth LLC lifted its stake in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after buying an additional 48 shares in the last quarter. MidFirst Bank purchased a new stake in shares of Humana during the second quarter valued at approximately $35,000. Finally, Montag A & Associates Inc. grew its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of analysts have commented on the company. Sanford C. Bernstein reissued an “outperform” rating and issued a $425.00 target price on shares of Humana in a report on Wednesday, June 3rd. Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target on the stock in a report on Thursday, July 30th. Wells Fargo & Company raised Humana from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $227.00 to $502.00 in a research report on Monday, July 13th. Barclays lifted their price objective on Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Truist Financial boosted their target price on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $403.91.
Humana Stock Down 0.3%
HUM opened at $384.25 on Tuesday. The firm’s 50 day simple moving average is $386.07 and its two-hundred day simple moving average is $290.60. The company has a market capitalization of $46.14 billion, a PE ratio of 36.35, a PEG ratio of 2.20 and a beta of 0.72. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period in the previous year, the firm earned $6.27 EPS. As a group, equities analysts forecast that Humana Inc. will post 9.12 EPS for the current year.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
